257 related articles for article (PubMed ID: 32964342)
1. Tocilizumab for the treatment of TAFRO syndrome: a systematic literature review.
Akiyama M; Kaneko Y; Takeuchi T
Ann Hematol; 2020 Nov; 99(11):2463-2475. PubMed ID: 32964342
[TBL] [Abstract][Full Text] [Related]
2. TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.
Sakai K; Maeda T; Kuriyama A; Shimada N; Notohara K; Ueda Y
Mod Rheumatol; 2018 May; 28(3):564-569. PubMed ID: 26886414
[TBL] [Abstract][Full Text] [Related]
3. Successful Treatment with Cyclosporin A in Tocilizumab-resistant TAFRO Syndrome.
Yamaga Y; Tokuyama K; Kato T; Yamada R; Murayama M; Ikeda T; Yamakita N; Kunieda T
Intern Med; 2016; 55(2):185-90. PubMed ID: 26781021
[TBL] [Abstract][Full Text] [Related]
4. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
Zhou Q; Zhang Y; Zhou G; Zhu J
BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
[TBL] [Abstract][Full Text] [Related]
5. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report.
Fujiwara Y; Ito K; Takamura A; Nagata K
J Med Case Rep; 2018 Oct; 12(1):295. PubMed ID: 30293532
[TBL] [Abstract][Full Text] [Related]
6. Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with Bilateral Adrenal Hemorrhage in Two Caucasian Patients.
Ducoux G; Guerber A; Durel CA; Asli B; Fadlallah J; Hot A
Am J Case Rep; 2020 Apr; 21():e919536. PubMed ID: 32249274
[TBL] [Abstract][Full Text] [Related]
7. Sequential change in serum VEGF levels in a case of tocilizumab-resistant TAFRO syndrome treated effectively with rituximab.
Wakiya R; Kameda T; Takeuchi Y; Ozaki H; Nakashima S; Shimada H; Kadowaki N; Dobashi H
Mod Rheumatol Case Rep; 2021 Jan; 5(1):145-151. PubMed ID: 33269653
[TBL] [Abstract][Full Text] [Related]
8. Optimal treatments for TAFRO syndrome: a retrospective surveillance study in Japan.
Fujimoto S; Kawabata H; Sakai T; Yanagisawa H; Nishikori M; Nara K; Ohara S; Tsukamoto N; Kurose N; Yamada S; Takai K; Aoki S; Masaki Y
Int J Hematol; 2021 Jan; 113(1):73-80. PubMed ID: 32970275
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
Fujiwara S; Mochinaga H; Nakata H; Ohshima K; Matsumoto M; Uchiba M; Mikami Y; Hata H; Okuno Y; Mitsuya H; Nosaka K
Int J Hematol; 2016 Jun; 103(6):718-23. PubMed ID: 26980221
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.
Shirai T; Onishi A; Waki D; Saegusa J; Morinobu A
Medicine (Baltimore); 2018 Jun; 97(23):e11045. PubMed ID: 29879072
[TBL] [Abstract][Full Text] [Related]
11. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
[TBL] [Abstract][Full Text] [Related]
12. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review.
Nagayama Y; Yamano M; Yagame M; Nariyama T; Takahashi M; Kawamoto M; Matsui K
BMC Nephrol; 2019 Oct; 20(1):375. PubMed ID: 31623576
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.
Kawabata H; Kotani S; Matsumura Y; Kondo T; Katsurada T; Haga H; Kadowaki N; Takaori-Kondo A
Intern Med; 2013; 52(13):1503-7. PubMed ID: 23812199
[TBL] [Abstract][Full Text] [Related]
14. Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide.
Kikuchi T; Shimizu T; Toyama T; Abe R; Okamoto S
Intern Med; 2017 Aug; 56(16):2205-2211. PubMed ID: 28781319
[TBL] [Abstract][Full Text] [Related]
15. [TAFRO syndrome and cutaneous necrotizing vasculitis].
Maquet J; Bories E; Nogier MB; Beck C; Aizel G; Toledano A; Faguer S; Paricaud K; Pugnet G; Moulis G; Astudillo L; Sailler L
Rev Med Interne; 2021 Feb; 42(2):134-139. PubMed ID: 33218790
[TBL] [Abstract][Full Text] [Related]
16. A case of TAFRO syndrome maintained in remission for 5 years after discontinuation of tocilizumab.
Yamagami K; Hanioka Y; Yao S; Nakamura R; Nakamura T; Ishii N; Goto H
Mod Rheumatol Case Rep; 2023 Jan; 7(1):205-210. PubMed ID: 35134213
[TBL] [Abstract][Full Text] [Related]
17. Tocilizumab-resistant TAFRO Syndrome Complicated by Type II Respiratory Failure.
Aoki T; Wada M; Kawashima A; Hirakawa K; Nagata A; Kagawa K
Intern Med; 2017 Dec; 56(23):3249-3254. PubMed ID: 29021431
[TBL] [Abstract][Full Text] [Related]
18. A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: The first case report in Latin America.
José FF; Kerbauy LN; Perini GF; Blumenschein DI; Pasqualin DDC; Malheiros DMAC; Campos Neto GC; de Souza Santos FP; Piovesan R; Hamerschlak N
Medicine (Baltimore); 2017 Mar; 96(13):e6271. PubMed ID: 28353560
[TBL] [Abstract][Full Text] [Related]
19. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.
Simeni Njonnou SR; Deuson J; Royer-Chardon C; Vandergheynst FA; Wilde V
BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606113
[TBL] [Abstract][Full Text] [Related]
20. Acute Kidney Injury Caused by TAFRO Syndrome in a Chinese Patient: Efficacy of Long-Term Corticosteroids Combined with Bortezomib and Cyclophosphamide.
Xia P; Zhang L; Zou M; Zhang T; Li R; Shi X; Wang J; Qin Y; Li X; Li J; Chen L
Kidney Blood Press Res; 2020; 45(4):623-630. PubMed ID: 32492687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
